PCR

The test adds to a growing menu of approved assays for the cobas 4800 system.

The company has also received approvals for various molecular diagnostics in the US and Canada in recent months.

The CTC-based oncology diagnostics firm raised $15.6 million in net proceeds from a public offering of its securities in February. 

The assays use specimens from symptomatic patients for the qualitative detection and differentiation of HSV-1 and HSV-2 with results generated within one hour. 

The firm received CLIA waiver of a strep A assay on its Liat platform yesterday, and a favorable evaluation of its influenza A/B assay was published last week.

Methods and compositions for DNA fragmentation and tagging by transposases
Helicase dependent isothermal amplification using nicking enzymes
Mutational analysis
Method for amplifying nucleic acids
Compositions, methods and kits for nucleic acid synthesis and amplification
Determination of KIR haplotypes associated with disease